These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16689315)

  • 21. Endometriosis and in vitro fertilisation: a review.
    Dechaud H; Dechanet C; Brunet C; Reyftmann L; Hamamah S; Hedon B
    Gynecol Endocrinol; 2009 Nov; 25(11):717-21. PubMed ID: 19908950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of clomiphene and menotropins as inducers of multiple follicular growth in a program of in vitro fertilization].
    García Luna A; Gorozpe J; Fuentes E; Murrieta S; Téllez J; González Diddi M
    Ginecol Obstet Mex; 1989 Oct; 57():281-6. PubMed ID: 2518618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.
    Gong F; Tang Y; Zhang H; Lu G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):185-9. PubMed ID: 19349670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple pregnancies in gonadotropin-stimulated cycles after human in vitro fertilization (IVF) and embryo replacement.
    Mettler L; Riedel HH; Bonhoff A; Michelmann HW
    Experientia; 1985 Dec; 41(12):1509-14. PubMed ID: 3935477
    [No Abstract]   [Full Text] [Related]  

  • 26. Basal serum pituitary hormone levels and outcome of in vitro fertilization utilizing a flare nasal gonadotropin releasing hormone agonist and fixed low-dose follicle-stimulating hormone/human menopausal gonadotropin regimen.
    Chan YF; Ho PC; So WW; Yeung WS
    J Assist Reprod Genet; 1993 May; 10(4):251-4. PubMed ID: 8130428
    [No Abstract]   [Full Text] [Related]  

  • 27. Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist.
    Schröder AK; Schöpper B; Al-Hasani S; Löning M; Diedrich K; Ludwig M
    Fertil Steril; 2003 Mar; 79(3):648-50. PubMed ID: 12620461
    [No Abstract]   [Full Text] [Related]  

  • 28. Friendly IVF: patient opinions.
    Højgaard A; Ingerslev HJ; Dinesen J
    Hum Reprod; 2001 Jul; 16(7):1391-6. PubMed ID: 11425818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ovarian insufficiency (so called 'poor responder')].
    Ohba T; Okamura Y; Okamura H
    Nihon Rinsho; 2006 Jun; Suppl 2():356-60. PubMed ID: 16817421
    [No Abstract]   [Full Text] [Related]  

  • 30. Progress in ovulation induction with gonadotropins.
    Gindoff PR; Jewelewicz R
    Bull N Y Acad Med; 1989 Jun; 65(5):574-82. PubMed ID: 2513078
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical application of the gonadotropin--ovulation induction].
    Fukui A; Kimura H; Fujii S; Mizunuma H
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():230-6. PubMed ID: 16689314
    [No Abstract]   [Full Text] [Related]  

  • 32. Extracorporeal fertilization of human oocytes and their replacement; suggested simplifications.
    Hamberger L; Sjögren A; Enk L; Wikland M
    Experientia; 1985 Dec; 41(12):1507-9. PubMed ID: 2934269
    [No Abstract]   [Full Text] [Related]  

  • 33. The poor-responder patient in an in vitro fertilization-embryo transfer program.
    Ben-Rafael Z; Feldberg D
    J Assist Reprod Genet; 1993 Feb; 10(2):118-20. PubMed ID: 8339013
    [No Abstract]   [Full Text] [Related]  

  • 34. Ovulation induction in 1995: a new policy.
    Fanchin R; Fernandez H; Olivennes F; Frydman R
    Hum Reprod; 1995 Sep; 10(9):2224-5. PubMed ID: 8530639
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple follicle development utilizing combinations of clomiphene citrate and human menopausal gonadotropins.
    Yee B; Vargyas JM
    Clin Obstet Gynecol; 1986 Mar; 29(1):141-7. PubMed ID: 3082551
    [No Abstract]   [Full Text] [Related]  

  • 36. Reply of the authors.
    Griesinger G; Mannaerts B; Andersen CY; Witjes H; Kolibianakis EM; Gordon K
    Fertil Steril; 2014 Jan; 101(1):e5-6. PubMed ID: 24289995
    [No Abstract]   [Full Text] [Related]  

  • 37. Diethylstilbestrol-induced müllerian abnormalities, septate uterus, genital tuberculosis and twin pregnancy with term delivery after in-vitro fertilization.
    Balasch J; Coll O; Jové I; Moreno V; Mulet J; Vanrell JA
    Hum Reprod; 1991 May; 6(5):690-3. PubMed ID: 1939551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does progesterone elevation compromise pregnancy rates in high responders? Insufficient evidence to draw a conclusion.
    Bosch E
    Fertil Steril; 2014 Jan; 101(1):e3-4. PubMed ID: 24289998
    [No Abstract]   [Full Text] [Related]  

  • 39. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.
    Fauser BC; Devroey P; Yen SS; Gosden R; Crowley WF; Baird DT; Bouchard P
    Hum Reprod; 1999 Nov; 14(11):2681-6. PubMed ID: 10548600
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical application of GnRH-antagonists.
    Felberbaum RE; Ludwig M; Diedrich K
    Mol Cell Endocrinol; 2000 Aug; 166(1):9-14. PubMed ID: 10989202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.